• Users Online: 589
  • Print this page
  • Email this page
Year : 2022  |  Volume : 4  |  Issue : 1  |  Page : 15

Use of the dexamethasone implant as an adjunct in the treatment of Coats disease in a pediatric patient

1 Instituto de Oftalmología y Glaucoma Vásquez, Quito, Retina Division, Ecuador
2 Pediatric Ophthalmology and Strabismus Department, Centro Medico Axxis, Quito, Ecuador
3 General Ophthalmology, Centro Médico Vista Integral, Quito, Ecuador

Correspondence Address:
Dr. Salcedo Hugo Ricardo
Jardines del Batán, Edificio Semirabad, Quito
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/pajo.pajo_125_21

Rights and Permissions

To report the use of intravitreal dexamethasone implant and its short-term efficacy in a pediatric patient with Coats' disease. A 7-year-old patient was referred to the clinic because of decreased visual acuity in the right eye of 10-month duration. Best-corrected visual acuity was 20/400. Funduscopic examination showed evidence of Stage 2B Coats' disease. The patient underwent treatment with laser photocoagulation, intravitreal injection of bevacizumab, and intravitreal injection of dexamethasone implant. During the 10-month follow-up, there was no evidence of side effects. Anatomical resolution was evident on funduscopic examination and macular optical coherence tomography, with best-corrected visual acuity being 20/60. Intravitreal dexamethasone implant was effective during the 10-month follow-up; providing improvement in visual acuity without any side effects.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded81    
    Comments [Add]    

Recommend this journal